美罗华
医学
膜性肾病
CD20
养生
肾病综合征
单中心
不利影响
内科学
胃肠病学
免疫学
肾小球肾炎
抗体
肾
作者
Paolo Cravedi,Piero Ruggenenti,Maria Chiara Sghirlanzoni,Giuseppe Remuzzi
摘要
Avoiding unnecessary reexposure to rituximab is extremely cost-saving and may limit the production of antichimeric antibodies that may increase the risk for adverse reactions and prevent re-treatment of disease recurrences.
科研通智能强力驱动
Strongly Powered by AbleSci AI